|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_ocn893722630 |
| 003 |
OCoLC |
| 005 |
20231120111833.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
141025s1979 nyua ob 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d N$T
|d E7B
|d S4S
|d EBLCP
|d DEBSZ
|d OCLCQ
|d YDXCP
|d UAB
|d MERUC
|d OCLCQ
|d OCLCO
|d OCLCA
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d VLY
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 897643919
|a 948685284
|a 1162188185
|
| 020 |
|
|
|a 9781483269573
|q (electronic bk.)
|
| 020 |
|
|
|a 1483269574
|q (electronic bk.)
|
| 020 |
|
|
|z 9780126355055
|
| 020 |
|
|
|z 0126355053
|
| 035 |
|
|
|a (OCoLC)893722630
|z (OCoLC)897643919
|z (OCoLC)948685284
|z (OCoLC)1162188185
|
| 050 |
|
4 |
|a QR186.5
|b A58 1979eb
|
| 060 |
|
4 |
|a QW 570
|b A629 1973
|
| 070 |
|
|
|a QR186.5
|b .S44
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.07/92
|2 23
|
| 245 |
0 |
4 |
|a The antigens.
|n Volume V /
|c edited by Michael Sela, Department of Chemical Immunology, the Weizmann Institute of Science, Rehovot, Israel.
|
| 264 |
|
1 |
|a New York :
|b Academic Press,
|c 1979.
|
| 300 |
|
|
|a 1 online resource (xiii, 410 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and indexes.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover; The Antigens; Copyright Page; Table of Contents; List of Contributors; Preface; Contents of Other Volumes; CHAPTER 1. Tumor Antigens; I. Introduction; II. Classic Studies of Tumor-SpecificTransplantation Antigens; III. Detection of Tumor Antigens; IV. Purification of Tumor Antigens; V. Nature of Tumor Antigens; VI. The Immune Response to Tumor Antigens; VII. The Role of Tumor Antigens in the Escapeof Tumors from Immunological Control; VIII. Human Tumor Antigens; IX. Conclusions; Acknowledgments; References; CHAPTER 2. Antigens of Helminths; I. Introduction.
|
| 505 |
8 |
|
|a II. Immunity to HelminthsIII. Pathophysiology of Antigens; IV. Applications: Immunodiagnosis and Immunoprevention; V. Concluding Remarks; Acknowledgments; References; CHAPTER 3. Cytotoxic Lymphocytes; I. Introduction; II. Assay of Lymphocyte-Mediated Cytotoxicity in Vitro; III. Cytolytic T Lymphocytes; IV. Antibody-Dependent Lymphocyte-Mediated Cytotoxicity; V. Natural Cytotoxicity Mediated by Lymphocytes; VI. Concluding Remarks; References; CHAPTER 4. Complement; I. Introduction; II. Complement Terminology; III. The Proteins of the Complement Sequence; IV. Components without Clear Homologue.
|
| 505 |
8 |
|
|a v. The Reaction Mechanisms of ComplementVI. Reaction Mechanisms of the Terminal Portionof the Complement Sequence; VII. Biosynthesis of Complement; VIII. The Biological Properties of the Complement System; IX. Complement as an Autoantigen; X. The Genetics of the Complement System; XI. Complement Components of Cell Membranes; XII. Complement in the Induction of the Antibody Response; References; Author Index; Subject Index.
|
| 546 |
|
|
|a English.
|
| 650 |
|
0 |
|a Antigens.
|
| 650 |
|
0 |
|a Immunochemistry.
|
| 650 |
|
0 |
|a Immune response.
|
| 650 |
|
0 |
|a Immunity.
|
| 650 |
|
2 |
|a Immunochemistry
|0 (DNLM)D007120
|
| 650 |
|
2 |
|a Antigens
|0 (DNLM)D000941
|
| 650 |
|
2 |
|a Immunity
|0 (DNLM)D007109
|
| 650 |
|
6 |
|a Antig�enes.
|0 (CaQQLa)201-0001668
|
| 650 |
|
6 |
|a Immunochimie.
|0 (CaQQLa)201-0017035
|
| 650 |
|
6 |
|a Immunit�e.
|0 (CaQQLa)201-0013310
|
| 650 |
|
6 |
|a R�eaction immunitaire.
|0 (CaQQLa)201-0013536
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Immunity
|2 fast
|0 (OCoLC)fst00967888
|
| 650 |
|
7 |
|a Antigens
|2 fast
|0 (OCoLC)fst00810523
|
| 650 |
|
7 |
|a Immune response
|2 fast
|0 (OCoLC)fst00967867
|
| 650 |
|
7 |
|a Immunochemistry
|2 fast
|0 (OCoLC)fst00967928
|
| 700 |
1 |
|
|a Sela, Michael,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Antigens. vol. 5.
|d New York ; London : Academic Press, 1979
|w (OCoLC)13833717
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780126355055
|z Texto completo
|
